Home » GLAXO WARNS OF BIRTH DEFECT FROM ANTIEPILEPTIC DRUG
GLAXO WARNS OF BIRTH DEFECT FROM ANTIEPILEPTIC DRUG
Drugmaker GlaxoSmithKline Plc. warned on Tuesday that there is an increased risk of cleft lip or cleft palate when the company's antiepileptic drug Lamictal is used during early pregnancy.
American
Medical Network
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May